September 17, 2021
September 10, 2021
September 8, 2021
September 17, 2021
September 16, 2021
September 15, 2021
September 16, 2021
Intent on bouncing back from a pair of later-phase clinical trial failures, Theravance Biopharma said it will eliminate about 75% of its workforce—270 jobs—and slash its R&D budget next year through a restructuring that will refocus the company on respiratory […]
September 8, 2021
The highly transmissible Delta variant of COVID-19 has highlighted a fear shared by infectious disease experts worldwide: That increasingly dangerous mutations will continue to crop up until most people around the globe are vaccinated. “There are going to be more […]
September 2, 2021
Johnson & Johnson drew sharp criticism two weeks ago amid reports that doses of its single-shot COVID-19 vaccine produced in South Africa were being exported to Europe. Now, it appears that the arrangement is coming to an end. J&J doses […]
September 15, 2021
Drugs.comModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today highlighted a new analysis suggesting that the Moderna COVID-19 vaccine is highly effective against circulating variants of concern, including in a vaccine effectiveness study conducted […]
September 14, 2021
FiercePharmaThe Senate and the FDA are appealing to the U.S. Patent and Trademark Office (USPTO) to examine how it can limit the ability of pharmaceutical companies to leverage patent strategies to extend their drug monopolies. In separate letters last week […]
September 14, 2021
FiercePharmaAcademic literature features a steady stream of papers on novel excipients with the potential to improve drug delivery but they rarely show up in newly approved drugs because companies shy away from the additional risk they entail. Recognizing that, the […]
Manufacturing, Research and Development
September 14, 2021
Contract PharmaAGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), unveiled expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects. With this expansion, AGC Biologics is boosting its current […]
Cell and Gene Therapy, Industry
September 13, 2021
Biopharma DiveWhile estimates vary, AMD is thought to affect a large number of people. A study published in 2014, for instance, projected the patient population globally would hit 196 million in 2020 and grow to 288 million by 2040. Among those […]
September 17, 2021
September 16, 2021
August 26, 2021
August 24, 2021
September 16, 2021
September 2, 2021
Copyright © 2021. All rights reserved
